Providence Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $6.7M
Latest Deal Amount
  • Investors
  • 1

Providence Therapeutics General Information

Description

Developer of a personalized mRNA cancer vaccine designed treat women with advanced ovarian cancer. The company's vaccine identify tumor mutations and elicit an immune response against the tumor cells, enabling users to treat themselves and live life to the fullest.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 661 University Avenue
  • Suite 1300
  • Toronto, Ontario M5G 0B7
  • Canada
+1 (403) 000-0000

Providence Therapeutics Timeline

2018201920202021
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Providence Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 23-Jul-2020 $6.7M 00.00 Completed Generating Revenue
2. Accelerator/Incubator 01-Feb-2018 00.00 Completed Generating Revenue
1. Angel (individual) 03-Aug-2016 $1.4M $1.4M Completed Generating Revenue
To view Providence Therapeutics’s complete valuation and funding history, request access »

Providence Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Bradley Sorenson Co-Founder, President, Chief Executive Officer & Board Member
Natalia Orozco Chief Development Officer
Eric Marcusson Ph.D Co-Founder & Chief Scientific Officer
Nicholas Dean Executive Officer & Board Member
Scott Leary MD Co-Founder & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

Providence Therapeutics Board Members (5)

Name Representing Role Since
Bradley Sorenson Providence Therapeutics Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Darlene Haslam Providence Therapeutics Board Member 000 0000
Ken Hughes Providence Therapeutics Chairman of the Board 000 0000
Nicholas Dean Providence Therapeutics Executive Officer & Board Member 000 0000
Scott Leary MD Providence Therapeutics Co-Founder & Board Member 000 0000
To view Providence Therapeutics’s complete board members history, request access »

Providence Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
JLABS Accelerator/Incubator 000 0000 000000 0
To view Providence Therapeutics’s complete investors history, request access »